Bausch Health Companies (BHC) Long-Term Deferred Tax (2009 - 2026)
Bausch Health Companies (BHC) posted Long-Term Deferred Tax of $1.8 billion for Q2 2026, little changed sequentially from $1.8 billion in Q1 2026, and down 8.89% YoY from $2.0 billion in Q2 2025.
Bausch Health Companies (BHC) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Long-Term Deferred Tax for 18 years, with the latest figure at $1.8 billion in Q2 2026.
- Quarterly Long-Term Deferred Tax fell 8.89% year-over-year to $1.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (down 8.89% YoY) and the FY2025 annual result came in at $1.8 billion, down 6.35% from the prior year.
- Long-Term Deferred Tax held at $1.8 billion in Q2 2026 per BHC's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $2.4 billion in Q3 2022 and troughed at $1.8 billion in Q4 2025.
- A 5-year average of $2.1 billion and a median of $2.2 billion in 2023 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax increased 6.14% in 2022, then slipped 8.89% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $2.2 billion in 2022, then slipped by 3.0% to $2.1 billion in 2023, then decreased by 6.33% to $2.0 billion in 2024, then fell by 6.35% to $1.8 billion in 2025, then climbed by 0.11% to $1.8 billion in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $1.8 billion, $1.8 billion, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Bn |
| Mar 31, 2026 | 1.85 Bn |
| Dec 31, 2025 | 1.84 Bn |
| Sep 30, 2025 | 2.05 Bn |
| Jun 30, 2025 | 2.03 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 1.97 Bn |
| Sep 30, 2024 | 2.19 Bn |
| Jun 30, 2024 | 2.19 Bn |
| Mar 31, 2024 | 2.15 Bn |
| Dec 31, 2023 | 2.10 Bn |
| Sep 30, 2023 | 2.19 Bn |
| Jun 30, 2023 | 2.19 Bn |
| Mar 31, 2023 | 2.16 Bn |
| Dec 31, 2022 | 2.17 Bn |
| Sep 30, 2022 | 2.37 Bn |
| Jun 30, 2022 | 2.28 Bn |
| Mar 31, 2022 | 2.28 Bn |
| Dec 31, 2021 | 2.25 Bn |
| Sep 30, 2021 | 2.27 Bn |